Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2010
10/28/2010US20100272644 Complexation of fatty acid-conjugated molecules with albumin
10/28/2010US20100272639 Polysaccharide nanoparticles
10/28/2010US20100270197 Multipurpose packages for sterile products or products to be sterilised
10/28/2010CA2759847A1 Rapeseed gene for heat shock protein hsp17.8 and use thereof
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759583A1 A tuberculosis tb vaccine to prevent reactivation
10/28/2010CA2759465A1 Method of producing polymers of spider silk proteins
10/28/2010CA2759425A1 Immunogenic epitopes of ngep antigen
10/28/2010CA2759325A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010CA2759311A1 Regulators involved in mushroom formation
10/28/2010CA2758842A1 Fgfr1c antibody combinations
10/28/2010CA2758792A1 Yield enhancement in plants by modulation of a maize transcription coactivator p15 (pc4) protein
10/28/2010CA2758445A1 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/28/2010CA2757706A1 A novel cell and therapeutical and diagnostical methods based thereon
10/28/2010CA2757079A1 Control of protein glycosylation and compositions and methods relating thereto
10/27/2010EP2243827A1 Serum-free mammalian cell culture medium, and uses thereof
10/27/2010EP2243793A1 A stabilized aqueous alpha-galactosidase composition and methods relating thereto
10/27/2010EP2243792A1 Methods of producing polymers of spider silk proteins
10/27/2010EP2243791A1 Cloning and recombinant production of Vespula venom protease and methods of use thereof
10/27/2010EP2243790A1 Isolated polynucleotide increasing alcohol tolerance of host cell, vector and host cell containing the same, and method of producing alcohol using the same
10/27/2010EP2243789A1 P.gingivalis antigenic composition
10/27/2010EP2243788A1 HIVCON: An HIV immunogen and uses thereof
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2242853A2 Compositions and methods of detecting post-stop peptides
10/27/2010EP2242770A2 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same
10/27/2010EP2242767A1 A method of obtaining purified heterologous insulins expressed in yeast
10/27/2010EP2242763A1 Anti-bacterial compositions
10/27/2010EP2242505A2 Glycoconjugation of polypeptides using oligosaccharyltransferases
10/27/2010EP2021356B1 Hiv vaccine
10/27/2010EP1982992B1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
10/27/2010EP1692160B1 Fgf-5 binding and supported peptides
10/27/2010EP1551762B1 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP1119627B1 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN1942583B Optimized expression of HPV 58 L1 in yeast
10/27/2010CN1912141B Identification of genes
10/27/2010CN1697839B Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
10/27/2010CN1468256B Purification of HBV antigens for use in vaccines
10/27/2010CN1384877B Rescue of mumps virus from cDNA
10/27/2010CN101874116A Plants having increased yield-related traits and a method for making the same
10/27/2010CN101874115A Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease
10/27/2010CN101874039A Protein
10/27/2010CN101874038A Methods for synthesis for therapeuthic anti-HIV peptides
10/27/2010CN101873865A Use of the sequence encoding the carboxyl-terminal domain of the heavy chain of tetanus toxin as a drug
10/27/2010CN101873854A Laminins, derivatives, and compositions including same and method for their therapeutic use
10/27/2010CN101870986A Efficient production method and application of antibacterial peptide plectasin
10/27/2010CN101870979A Insecticidal gene cryX with high toxicity to lepidopterous pests and application thereof
10/27/2010CN101870977A Method for cultivating anti-cyanosis transgenic cotton and special expression vector thereof
10/27/2010CN101870976A Gene synthesis duck alpha interferon gene and protein expression
10/27/2010CN101870975A Partridge B-cell activating factor cDNA and cloning method and recombinant application thereof
10/27/2010CN101870963A Recombinant Newcastle disease virus attenuated vaccine strain for expressing dog interferon (alpha, beta or gamma)
10/27/2010CN101870729A Coagulation factor vii polypeptides
10/27/2010CN101870728A Novel Exendin variant and conjugate thereof
10/27/2010CN101870727A Protein related to rice grain shape and height and coding gene and application thereof
10/27/2010CN101358194B Spirulina phycobiliprotein alpha subunit total protein gene and encoding protein thereof
10/27/2010CN101173290B Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same
10/27/2010CN101070542B Intensified tubercle-resisting action of human interleukin 24
10/27/2010CN101044162B GLP-1 analog fusion protein formulations
10/26/2010USRE41888 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
10/26/2010US7820890 Inbred corn line G07-NPXA6496
10/26/2010US7820879 generating petunia transformants overexpressing the ZPT2-3 gene under the control of the CamV 35S promoter ; no adverse effects on plant growth
10/26/2010US7820877 Human heavy chain variable regions, human kappa light chain variable regions and encodes only mu isotype; human kappa light chain variable regions and encodes mu and gamma-2 isotypes; double-inactivated mouse Ig locus
10/26/2010US7820876 Animal model for evaluating neurodegenerative disorders and identifying neuroprotective agents
10/26/2010US7820801 producing solid proteinase K which is insoluble in water and has high purity; adding to an aqueous solution of proteinase K ammonium sulfate in small amounts up to final amount of 1.5 to 2 M after 1 hour, thereby precipitating the proteinase K as a solid
10/26/2010US7820800 Process for the purification of IL-18 binding protein
10/26/2010US7820796 Methods for producing Factor VIII proteins
10/26/2010US7820793 IFN-λ polypeptides and compositions
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820791 PBO-5 and/or PBO-8 and/or a H+-gated channel composed of PBO-5 and PBO-8 isolated from a vertebrate organism
10/26/2010US7820790 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases
10/26/2010US7820789 Streptococcal virulence factor for use in developing vaccines for treatment and prevention of pneumonia, meningitis and bacteraemia
10/26/2010US7820788 injection comprising paclitaxel and albumin to reduce side effects; drugs such as propofol or paclitaxel; for cancer, arthritis, or restenosis
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820784 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
10/26/2010US7820620 Cripto antagonism of activin and TGF-b signaling
10/26/2010US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics
10/26/2010US7820617 Administering peptide to person sensitive to diabetes; measurement, calibration
10/26/2010US7820453 Reacting astemizole with potassium channel moderators; complexing; calibration; kits
10/26/2010US7820447 drug screening; for carcinomas, especially lymphoma carcinomas
10/26/2010US7820441 Production of viral vectors
10/26/2010US7820424 Modified hydrolase for use as template for inverse polymerase chain reaction
10/26/2010US7820413 Incrementally truncated nucleic acids and methods of making same
10/26/2010US7820409 Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera
10/26/2010US7820397 Human or rodent Stromal Interacting Molecule (STIM) 1 protein; for treatment of diseases associated with calcium dysregulation
10/26/2010US7820395 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads
10/26/2010US7820393 Immunoglobulin which recognizes multiple antigenic peptides (MAP) for use in the diagnosis and differentiation between glandular and bone disorders
10/26/2010US7820392 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/26/2010US7820390 Methods of and kits and compositions for diagnosing colorectal tumors
10/26/2010US7820384 Methods and compositions for protein expression and purification
10/26/2010US7820379 Process for high throughput screening of CpG-based immuno-agonist/antagonist
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820226 Production of flax protein isolate
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820183 injected into the lower leg muscle of infants, before applying a first cast for effective therapy in correcting this physical deformity; neuromuscular inhibitors; avoid surgery